ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Kidney"

  • Abstract Number: 2401 • 2017 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis with Kidney Dysfunction Contributes to Higher Risk of Cardiovascular Disease Development

    Suad Hannawi1 and Issa Al Salmi2, 1Rheumatology, Asst.Prof, Dubai, United Arab Emirates, 2Prof, Muscat, Oman

    Background/Purpose: Reduced kidney function render patients with RA rheumatoid arthritis (RA), have an increased risk of cardtiovascular disease (CVD), particulary ischemic heart disease (IHD). This…
  • Abstract Number: 2846 • 2017 ACR/ARHP Annual Meeting

    Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Renal-Related and Decreased Risk of Dementia-Related Death

    Ana Beatriz Vargas-Santos1, Tuhina Neogi2, Geraldo Castelar-Pinheiro1 and Aleksandra Turkiewicz3, 1Internal Medicine - Rheumatology, State University of Rio de Janeiro, Rio de Janeiro, Brazil, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Clinical Sciences Lund, Orthopedics, Clinical Epidemiology Unit, Lund University, Lund, Sweden

    Background/Purpose: There is recognized higher mortality among gout patients, with cardiovascular (CV) mortality having been previously reported. The present study aimed to examine cause-specific mortality…
  • Abstract Number: 322 • 2017 ACR/ARHP Annual Meeting

    Safety of Denosumab in a Monocentric Cohort of Kidney Transplant Recipients

    Sonia Doddoli, Pierre Lafforgue and Thao Pham, Rheumatology, APHM, Aix Marseille Univ, Marseille, France

    Background/Purpose: Safety of denosumab, a fully human monoclonal antibody against RANKL developed for osteoporosis and prevention of fracture remains unclear in kidney transplanted patients. A…
  • Abstract Number: 1026 • 2017 ACR/ARHP Annual Meeting

    Gene Expression Analysis Reveals Common Pathways of Tissue Pathogenesis in Lupus Organ Involvement

    Amrie Grammer1, Sarah Heuer1, Robert Robl1, Adam Labonte1, Prathyusha Bachali1, Sushma Madamanchi1 and Peter E. Lipsky2, 1AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA, 2AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Lupus is a prototypic autoimmune disease characterized by B cell hyperactivity, autoantibody formation and resultant tissue damage. The mechanisms underlying tissue pathology in lupus…
  • Abstract Number: 1108 • 2017 ACR/ARHP Annual Meeting

    Effect of Body Mass Index on Serum Urate and Renal Uric Acid Handling Responses to an Oral Inosine Load

    Nicola Dalbeth1, Jordyn de Kwant1, Gregory Gamble2, Amanda Phipps-Green3, Anne Horne2, Lisa K. Stamp4 and Tony R. Merriman5, 1University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3University of Otago, Dunedin, New Zealand, 4University of Otago, Christchurch, New Zealand, 5Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand

    Background/Purpose:  Increased body mass index (BMI) is an important risk factor for hyperuricemia and gout. It is unknown whether overweight and obesity influences serum urate…
  • Abstract Number: 1122 • 2017 ACR/ARHP Annual Meeting

    Prevalence of Chronic Kidney Disease and Uncontrolled Serum Uric Acid Levels in US Adult Gout Population: Results from the National Health and Nutrition Examination Survey 2007–2012

    Jean J. Lim1,2, An-Chen Fu2, David S. Reasner2 and Douglas C.A. Taylor2, 1Tufts University School of Medicine, Botson, MA, 2Ironwood Pharmaceuticals, Inc., Cambridge, MA

    Background/Purpose: Gout is the most common form of inflammatory arthritis, mainly caused by elevated serum uric acid (sUA) levels. The American College of Rheumatology guidelines…
  • Abstract Number: 1921 • 2017 ACR/ARHP Annual Meeting

    Urine Angiostatin and VCAM-1 Surpass Conventional Metrics in Predicting Elevated Renal Pathology Activity Indices in Lupus Nephritis

    Samar Soliman1,2, Fatma Mohamed3, Faten Ismail3, Ramesh Saxena4 and Chandra Mohan2, 1Rheumatology and rehabilitation, University of Minya, Minya, Egypt, 2Biomedical Engineering, University of Houston, Houston, TX, 3Rheumatology and Rehabilitation, University of Minya, Minya, Egypt, 4Internal Medicine/Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: The goal of this study is to investigate how urinary angiostatin, VCAM-1 and established measures of renal function relate to specific histologic findings in…
  • Abstract Number: 2052 • 2017 ACR/ARHP Annual Meeting

    Apply Musculoskeletal Ultrasonography to Predict Chronic Gouty Arthritis in Patients with Chronic Kidney Diseases

    Zheng-Hao Huang1, Chi-Ching Chang2, En Chao3, Hui-Hsun Chiang4, Shu-Yi Lin5, Kun-Lin Wu6, Hsiang-Cheng Chen5, Shi-Jye Chu5, San-Yuan Kao5, Tsung-Yun Hou5, Feng-Cheng Liu5, Chen-Hung Chen7, Deh-Ming Chang8 and Chun-Chi Lu9, 1Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital; Tri-service general hospital, National Defense Medical Center, Taipei, Taiwan, 2Taipei Medical University Hospital, Taipei, Taiwan, 3Tri-Service General Hospital Songshan Branch, Taipei, Taiwan, 4School of Nursing, National Defense Medical Center, Taipei, Taiwan, 5Tri-Service General Hospital, Taipei, Taiwan, 6Armed Forces Taoyuan General Hospital, Taipei, Taiwan, 7Taipei Tzu Chi hospital, Taipei, Taiwan, 8Taipei Veterans General Hospital, Taipei, Taiwan, 9University of Washington; Tri-Service General Hopsital, National Defense Medical Center, Seattle, WA

    Background/Purpose: Gouty arthritis, caused by the deposition of monosodium urate (MSU) monohydrate crystals at joints, is comprised of multiple inflammatory processes in synovium, tendons, cartilages…
  • Abstract Number: 211 • 2016 ACR/ARHP Annual Meeting

    Safety and Efficacy of Febuxostat in Advanced CKD Patients with Hyperuricemia

    Yoon-Jeong Oh1, Seung Min Jung1, Sang-Won Lee2, Yong-Beom Park2 and Jason Jungsik Song2, 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose:  Dosing adjustments and increased risk of serious side effects of uric acid lowering agents in patients with reduced renal function lead to undercorrection of…
  • Abstract Number: 346 • 2016 ACR/ARHP Annual Meeting

    Interest of Bone Texture Assessment By Trabecular Bone Score (TBS) in Kidney Transplants Recipients

    Marie Aubé1, Alain Daragon1, Olivier Vittecoq2, Dominique Bertrand3, Mathilde Lemoine3, Jean François Menard4 and Christopher Banse5, 1Rheumatology, CHU Hôpitaux de Rouen, Rouen, France, 2Rheumatology, Rouen University Hospital &INSERM U905, Rouen, France, 3Nephrology, CHU Hôpitaux de Rouen, Rouen, France, 4Biostatistics, Université de Rouen, Rouen, France, 5Rheumatology, Rouen University Hospital, Rouen, France

    Background/Purpose: Osteoporosis in kidney transplant is complex and multifactorial. We studied the evolution of Trabecular Bone Score (TBS) and bone mineral density (BMD) in kidney…
  • Abstract Number: 352 • 2016 ACR/ARHP Annual Meeting

    Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?

    Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan

    Background/Purpose:  This study investigated whether bone mineral density (BMD) affects readmission risk in patients with CKD who received denosumab therapy. Methods: All subjects underwent dual…
  • Abstract Number: 353 • 2016 ACR/ARHP Annual Meeting

    Changes in Femoral Neck Bone Mineral Density Inverse Correlate with Egfr in Denosumab Treated Osteoporosis Patients? a Hospital-Based Analysis

    Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan

    Background/Purpose:  This study investigated the effect of different severities of CKD on bone mineral density (BMD) in patients treated with denosumab. Methods: This study was…
  • Abstract Number: 912 • 2016 ACR/ARHP Annual Meeting

    Urate Lowering Therapy in Moderate to Severe Chronic Kidney Disease

    Gerald D. Levy1,2, Craig Cheetham3, Nazia Rashid4 and Jiaxiao Shi3, 1Internal Medicine/Rheumatology, Southern California Kaiser Permanente, Downey, CA, 2Rheumatology, Kaiser Permanente Southern California, Downey, CA, 3Research and Evaluation, Southern California Medical Group, Pasadena, CA, 4Pharmacy Analytic Services, Kaiser Permanente, Downey, CA

    Urate Lowering Therapy in Moderate to Severe Chronic Kidney Disease Levy G, Cheetham C, Shi J, Rashid N Background/Purpose:   To determine if urate lowering…
  • Abstract Number: 1865 • 2016 ACR/ARHP Annual Meeting

    Urinary Cell Adhesion Molecules As Markers of Renal Involvement in Systemic Sclerosis

    Edward Stern1, Voon H. Ong2, Aine Burns3, Robert Unwin4 and Christopher Denton5, 1UCL Division of Medicine, London, United Kingdom, 2Rheumatology, UCL Division of Medicine, London, United Kingdom, 3Nephrology, Royal Free Hospital, London, United Kingdom, 4Nephrology, UCL Division of Medicine, London, United Kingdom, 5Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom

    Background/Purpose: Renal involvement in systemic sclerosis (SSc) includes scleroderma renal crisis as well as progressive organ fibrosis. Detection and management of these disease complications is…
  • Abstract Number: 3129 • 2016 ACR/ARHP Annual Meeting

    The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and Allopurinol

    Matthew Doogue1, Dan Wright2, Nick Cross3, John Irvine3, Peter T. Chapman4, Murray Barclay5 and Lisa K. Stamp1, 1University of Otago, Christchurch, New Zealand, 2School of Pharmacy, University of Otago, Dunedin, New Zealand, 3Nephrology, Christchurch Hospital, Christchurch, New Zealand, 4Christchurch Hospital, Christchurch, New Zealand, 5Medicine, University of Otago, Christchurch, New Zealand

    Background/Purpose: Allopurinol is recommended as a first-line pharmacologic urate-lowering therapy in gout. Oxypurinol, the active metabolite of allopurinol, is entirely cleared by the kidneys. Oxypurinol…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology